Cytek Biosciences, Inc. (CTKB)
NASDAQ·Healthcare·Medical - Devices
$4.58
+2.58%
Mkt Cap $565.62M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $57.15M | $62.14M | +8.73% | -$0.02 | -$0.01 | +50.00% | — | — |
| Q4 2025 Nov 5, 2025 | $58.80M | $52.29M | -11.07% | $0.01 | -$0.01 | -200.00% | — | — |
| Q3 2025 Aug 6, 2025 | $46.35M | $45.60M | -1.61% | -$0.02 | $0.01 | +150.00% | — | — |
| Q2 2025 May 8, 2025 | $42.66M | $41.46M | -2.83% | -$0.04 | -$0.09 | -125.00% | — | — |
| Q1 2025 Feb 27, 2025 | $59.38M | $57.48M | -3.21% | $0.05 | $0.07 | +40.00% | — | — |
| Q4 2024 Nov 5, 2024 | $60.89M | $51.50M | -15.42% | $0.00 | $0.01 | +166.67% | — | — |
| Q3 2024 Aug 6, 2024 | $50.70M | $46.62M | -8.05% | -$0.03 | -$0.08 | -166.67% | — | — |
| Q2 2024 May 8, 2024 | $43.59M | $44.86M | +2.91% | -$0.05 | -$0.05 | +0.00% | — | — |
| Q1 2024 Mar 13, 2024 | $56.58M | $58.23M | +2.92% | $0.03 | $0.07 | +133.33% | — | — |
| Q4 2023 Nov 7, 2023 | $55.48M | $48.00M | -13.48% | -$0.33 | $0.01 | +103.00% | — | — |
| Q3 2023 Aug 8, 2023 | $57.64M | $49.69M | -13.79% | -$0.01 | $0.01 | +200.00% | — | — |
| Q2 2023 May 9, 2023 | $45.72M | $37.09M | -18.88% | -$0.01 | -$0.03 | -100.00% | — | — |
| Q1 2023 Feb 28, 2023 | $47.15M | $164.04M | +247.90% | $0.05 | $0.07 | +40.00% | — | — |
| Q4 2022 Nov 9, 2022 | $43.29M | $40.48M | -6.49% | $0.02 | $0.04 | +100.00% | — | — |
| Q3 2022 Aug 10, 2022 | $39.63M | $40.16M | +1.34% | $0.02 | $0.03 | +79.96% | — | — |
| Q2 2022 May 11, 2022 | $32.51M | $35.06M | +7.86% | $0.00 | $0.01 | +300.00% | — | — |
| Q1 2022 Feb 23, 2022 | $36.42M | $38.89M | +6.79% | $0.04 | $0.05 | +19.99% | — | — |
| Q4 2021 Nov 8, 2021 | $30.41M | $34.38M | +13.05% | $0.02 | $0.02 | -14.27% | — | — |
| Q3 2021 Sep 3, 2021 | — | $30.41M | — | — | $0.02 | — | — | — |
| Q3 2021 Jul 27, 2021 | — | $24.27M | — | — | $0.00 | — | — | — |